Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist, Suppresses Rat Prostate Carcinogenesis

Pioglitazone (PGZ), a peroxisome proliferator-activated receptor γ agonist, which is known as a type 2 diabetes drug, inhibits cell proliferation in various cancer cell lines, including prostate carcinomas. This study focused on the effect of PGZ on prostate carcinogenesis using a transgenic rat for...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Mol Sci
Asıl Yazarlar: Suzuki, Shugo, Mori, Yukiko, Nagano, Aya, Naiki-Ito, Aya, Kato, Hiroyuki, Nagayasu, Yuko, Kobayashi, Mizuho, Kuno, Toshiya, Takahashi, Satoru
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5187871/
https://ncbi.nlm.nih.gov/pubmed/27973395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17122071
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller